Global Smart Drug Delivery Systems Market Outlook 2025-2034:

Published 1 day ago• 6 minute read

Smart Drug Delivery Systems Market Size

The Smart Drug Delivery Systems Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Smart Drug Delivery Systems Market Size and Projected Growth Rate?
There has been significant growth in the smart drug delivery systems market over recent years. It is forecasted to expand from $12.65 billion in 2024 to $15.17 billion in 2025, indicating a compound annual growth rate (CAGR) of 19.9%. Factors contributing to its growth during the historic period include heightened demand for these delivery systems, greater patient compliance, a growing incidence of chronic diseases, the rise in personalized medicine and the requirement for affordable healthcare solutions.

Anticipated to witness substantial growth in the years to come, the smart drug delivery systems market is predicted to expand to a staggering $31.01 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 19.6%. The projected expansion during the forecast period is believed to be driven by factors like the escalating pressure of non-communicable diseases, a heightened focus on precision medicine, the emergence of theragnostics, a rising demand for non-invasive methods of drug delivery, and an uptick in healthcare expenditure. The key trends that will shape this market during the forecast period include the advent of miniaturization and microfabrication technologies, advancements in material science, the integration of artificial intelligence (AI) and machine learning (ML), the creation of nano-sized drug delivery systems, and the amalgamation of IoT and wearable technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14796

What Are the Major Segments in the Smart Drug Delivery Systems Market?
The smart drug delivery systems market covered in this report is segmented -

1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users

Subsegments:
1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors
3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors
4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors
5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors
6) By Other Products: Smart Syringes, Smart Patches, Smart Implants

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp

What Are The Driving Smart Drug Delivery Systems Market Evolution?
The escalating occurrence of chronic ailments is predicted to fuel the expansion of the smart drug delivery systems market in the future. Chronic ailments are prolonged health issues that gradually develop over a period and commonly have intricate origins. The incidence of chronic diseases is on the rise due to the aging population, environmental factors, and disparities in healthcare facilities. Smart drug delivery systems provide an optimistic method to control chronic diseases by improving the efficacy of medicines and enhancing patient compliance. As an illustration, data from the National Library of Medicine, an American medical library, mentioned in January 2023 that by 2050, around 142.66 million individuals will be suffering from at least one chronic disease, marking a 99.5% surge from 71.522 million in 2020. Hence, the increasing occurrence of chronic diseases is instigating the growth of the smart drug delivery systems market.

Which Firms Dominate The Smart Drug Delivery Systems Market Segments?
Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

What Trends Are Driving Growth in The Smart Drug Delivery Systems Market?
Leading corporations in the smart drug delivery systems market are concentrating their efforts on creating reusable drug delivery devices, such as Qfinity, as a way to modernise how drugs are administered. Traditional single-use devices are thrown away after one use, whereas Qfinity can be used multiple times. In detail, Jabil Inc., a manufacturing services company based in the US, unveiled Qfinity in May 2022. This recurring drug delivery device is tailored for subcutaneous self-administration of medications and able to sustain over 100 injections per device. It accommodates either 1 mL or 2.25 mL pre-filled cartridges, resulting in a 60% reduction in carbon emissions per injection. The Qfinity autoinjector platform is adaptable with comprehensive technical specifications for drug volumes and viscosities. To take it a step further, a connected variant called Qfinity+ ensures remote patient monitoring and adherence thanks to integrated sensors and electronics. This advanced version maintains functionality while also providing seamless communication.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Which Is The Largest Region In The Smart Drug Delivery Systems Market?
North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Smart Drug Delivery Systems Market?
2. What is the CAGR expected in the Smart Drug Delivery Systems Market?
3. What Are the Key Innovations Transforming the Smart Drug Delivery Systems Industry?
4. Which Region Is Leading the Smart Drug Delivery Systems Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Origin: